文献速递神经肿瘤功能神经外科

成人胶质瘤患者神经认知功能纵向变化的遗传调控

Genetic modulation of longitudinal change in neurocognitive function among adult glioma patients.
PubMed 文献 · J Neurooncol · 2021-11-24

研究纳入102例成人胶质瘤患者,术后平均随访1.3年,纵向评估言语记忆、处理速度和执行功能,检测580个基因多态性。发现端粒酶、DNA修复和认知通路的多态性与处理速度和执行功能纵向变化相关,联合效应分析显示显著遗传剂量效应。

要点

  • 端粒酶通路MCPH1 rs17631450和CCDC26 rs7005206与处理速度变化强相关。
  • DNA修复通路FANCF rs1514084和认知通路DAOA rs12428572与执行功能变化相关。
  • 多变量分析中,疾病进展、较低基线NCF和更多风险遗传变异是NCF下降的预测因素。

核心结论

  • 端粒酶、DNA修复和认知通路的多态性是胶质瘤患者神经认知功能下降的独立预测因素。

研究设计与样本

  • 纵向研究纳入102例成人胶质瘤患者,术后完成神经认知功能评估,平均随访间隔1.3年,检测580个基因多态性,涉及炎症、DNA修复、代谢、认知和端粒酶五条通路。

主要发现

  • 5个多态性与处理速度纵向变化相关,14个多态性与执行功能纵向变化相关。
  • 处理速度变化与端粒酶通路MCPH1 rs17631450(P=2.2×10-7)和CCDC26 rs7005206(P=9.3×10-7)强相关。
  • 执行功能变化与DNA修复通路FANCF rs1514084(P=2.9×10-6)和认知通路DAOA rs12428572(P=2.4×10-5)相关性更强。
  • 联合效应分析显示处理速度纵向变化(Ptrend=1.5×10-10)和执行功能纵向变化(Ptrend=2.1×10-11)存在显著遗传剂量效应。
  • 多变量分析中,调整年龄、性别、教育、肿瘤位置、组织学和疾病进展后,NCF下降的预测因素包括疾病进展、较低基线NCF表现和更多风险遗传变异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Impaired neurocognitive function (NCF) is extremely common in patients with higher grade primary brain tumor. We previously reported evidence of genetic variants associated with NCF in glioma patients prior to treatment. However, little is known about the effect of genetic variants on NCF decline after adjuvant therapy. METHODS: Patients (N = 102) completed longitudinal NCF assessments that included measures of verbal memory, processing speed, and executive function. Testing was conducted in the postoperative period with an average follow up interval of 1.3 years. We examined polymorphisms in 580 genes related to five pathways (inflammation, DNA repair, metabolism, cognitive, and telomerase). RESULTS: Five polymorphisms were associated with longitudinal changes in processing speed and 14 polymorphisms with executive function. Change in processing speed was strongly associated with MCPH1 rs17631450 (P = 2.2 × 10-7) and CCDC26 rs7005206 (P = 9.3 × 10-7) in the telomerase pathway; while change in executive function was more strongly associated with FANCF rs1514084 (P = 2.9 × 10-6) in the DNA repair pathway and DAOA rs12428572 (P = 2.4 × 10-5) in the cognitive pathway. Joint effect analysis found significant genetic-dosage effects for longitudinal changes in processing speed (Ptrend = 1.5 × 10-10) and executive function (Ptrend = 2.1 × 10-11). In multivariable analyses, predictors of NCF decline included progressive disease, lower baseline NCF performance, and more at-risk genetic variants, after adjusting for age, sex, education, tumor location, histology, and disease progression. CONCLUSION: Our longitudinal analyses revealed that polymorphisms in telomerase, DNA repair, and cognitive pathways are independent predictors of decline in NCF in glioma patients.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Wefel JS, Zhou R, Sulman EP, et al. Genetic modulation of longitudinal change in neurocognitive function among adult glioma patients. J Neurooncol. 2021. PMID: 34817796. doi:10.1007/s11060-021-03905-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。